BioGaia Gastrus IBS Review 2026: Legit or Overhyped?
Read before you buy. — Overhyped
-
"Bacteria reach the intestine in biologically active form"
Clinical trials confirm DSM 17938 survives gut transit and colonizes at studied doses.
PubMed: L. reuteri DSM 17938 survival studies -
"Product named 'IBS' implying it treats IBS symptoms"
The strongest human evidence for these two strains is in infant colic and children's diarrhea, not adult IBS.
PubMed: L. reuteri DSM 17938 clinical trial data -
"£89.82 sale price, discounted from £130"
BioGaia Gastrus capsules are commonly sold by other UK retailers for roughly half this price.
-
"No CFU count listed on the product page"
Without a stated CFU per capsule, you can't check if the dose matches the roughly 100 million to 1 billion CFU/day used in trials.
Internal: dose transparency check
Consumer advice
Check the price against BioGaia's official site or major pharmacies/Amazon before buying — this specific product often retails much lower elsewhere, and the £130 "regular price" here looks like an anchor to make £89.82 seem like a deal. If you have IBS specifically, know that the clinical evidence for this exact two-strain combo treating IBS symptoms is thin; the stronger data for these strains is in infant colic and pediatric diarrhea. A cheaper single-strain L. reuteri product or a different well-studied probiotic may serve you just as well for general gut support.
Claims vs Evidence
MODEST3 claims assessed. These grades assess the marketing claims, not the whole product. See each explanation for the evidence and its limits.
"supplements the natural bacterial microflora of the gastrointestinal tract"
Partial
Reasonable for probiotics generally, but not IBS-specific proof
Based on: L. reuteri DSM 17938, L. reuteri ATCC PTA 6475
Source: Examine.com/PubMed knowledge base on L. reuteri strains
"product name implies IBS benefit"
Stretch
Strongest evidence is pediatric diarrhea and infant colic, not adult IBS
Based on: L. reuteri DSM 17938, L. reuteri ATCC PTA 6475
Source: Internal: knowledge base review of L. reuteri strain studies
"bacteria are uniquely adapted and reach intestine in biologically active form"
Supported
Clinical studies confirm these strains survive gut transit
Based on: L. reuteri DSM 17938, L. reuteri ATCC PTA 6475
Source: PubMed: L. reuteri DSM 17938 clinical data
1 supported · 1 partial · 1 stretch
Ingredients
Based on peer-reviewed research from PubMed and Examine.com
Why the chain breaks for this product
Most ingredients below have real research behind them. The problem isn't the ingredients — it's the doses. 2 of 4 are not disclosed on the label, so the product can claim the benefits without delivering the chain that gets you there.
Probiotic strain with solid evidence for shortening kids' diarrhea and reducing gut pain long-term.
Research-backed dose: 1×10⁸ CFU daily (children); higher doses used in some emergency settings
In this product: not specified (CFU count not disclosed)
Probiotic strain with early evidence for bone health and gut microbiota support in older women.
In this product: not specified (CFU count not disclosed)
L. reuteri DSM 17938
Probiotic strain with solid evidence for shortening kids' diarrhea and reducing gut pain long-term.
Research-backed dose: 1×10⁸ CFU daily (children); higher doses used in some emergency settings
In this product: Dose not disclosed
L. reuteri ATCC PTA 6475
Probiotic strain with early evidence for bone health and gut microbiota support in older women.
Safety & side effects
What NIH says about the ingredients in this product. This describes the ingredients, not tests of this product, and it is not medical advice. Ask a doctor or pharmacist first if you take medication, are pregnant or nursing, or have a health condition.
Probiotics
Probiotics are unlikely to cause harm in healthy people, and side effects are usually minor. They have been linked to bacteremia, fungemia, and infections that caused severe illness, mostly in people who were severely ill or immunocompromised.
Possible side effects
- Side effects are usually minor and consist of self-limited gastrointestinal symptoms such as gas.
Serious risks
- Probiotic use has been linked to bacteremia, fungemia, and infections that led to severe illness, mostly in severely ill or immunocompromised people.
- Severe or fatal infections have been reported in premature infants given probiotics, and the FDA has warned health care providers.
- In a Boston ICU analysis, 6 of 522 patients given LGG had the ingested LGG found in their blood, versus 2 of 21,652 who did not receive it.
- Possible harms include infections, harmful substances produced by the probiotic microorganisms, and transfer of antibiotic resistance genes.
- Some products have contained microorganisms not listed on the label, which in some instances may pose serious health risks.
Avoid or ask a doctor first if
- For high-risk people such as premature infants or seriously ill hospital patients, the risks of probiotics should be carefully weighed against their benefits.
- For people with compromised immune function or other serious underlying diseases, the WGO advises restricting probiotic use to strains and indications with proven efficacy.
- Consult a health care provider before taking a probiotic supplement, especially with health problems. Anyone with a serious underlying condition should be monitored closely.
Source: NIH Office of Dietary Supplements, Probiotics: Fact Sheet for Health Professionals, NIH NCCIH, Probiotics: Usefulness and Safety
Price & Value
Extreme MarkupBioGaia Gastrus IBS
£89.82
BioGaia Gastrus (same product via pharmacy or Amazon UK)
Often £25-45 for 30-60 capsules from other UK retailers
Research sources: PubMed · Examine.com
Analyzed product: https://eliveragroup.com/products/biogaia-gastrus-ibs-60-capsules
Analysis generated: 2026-08-22 · Engine v1.0.0
Frequently Asked Questions
Is BioGaia Gastrus IBS worth the money?
BioGaia Gastrus IBS at £89.82 appears to offer reasonable value based on its ingredient quality and dosing. This is a legitimate, real probiotic product with two well-characterized L. reuteri strains that do have some clinical backing, mostly in children and for specific outcomes (diarrhea duration, gum inflammation) rather than IBS in adults. The product's own label is appropriately modest ("supplements the natural bacterial microflora," "not a substitute for a varied diet"), but the retailer's
Is BioGaia Gastrus IBS a scam?
BioGaia Gastrus IBS does not appear to be a scam. Our analysis found the claims are generally supported by the ingredients.
What are the ingredients in BioGaia Gastrus IBS?
BioGaia Gastrus IBS contains 4 ingredients including Lactobacillus reuteri DSM 17938, Lactobacillus reuteri ATCC PTA 6475, L. reuteri DSM 17938, L. reuteri ATCC PTA 6475.
Does BioGaia Gastrus IBS actually work?
Yes, BioGaia Gastrus IBS can work for its intended purpose. 1 of 3 claims are fully supported. 1 are partially supported.
Are there cheaper alternatives to BioGaia Gastrus IBS?
Yes, BioGaia Gastrus (same product via pharmacy or Amazon UK) at Often £25-45 for 30-60 capsules from other UK retailers offers similar benefits at a better price point. Many key ingredients in BioGaia Gastrus IBS are available separately for less.
Does BioGaia Gastrus IBS have side effects?
NIH summaries of the ingredients in BioGaia Gastrus IBS note these possible effects. Probiotics: Side effects are usually minor and consist of self-limited gastrointestinal symptoms such as gas. This describes the ingredients, not tests of this product; ask a doctor or pharmacist.